Pyxis Oncology, Inc.
PYXS
Revenue
16.15M
▲16.15M∞%
-Assets
208.39M
▼-11.83M▼-5.37%
3 Months ChangeLiabilities
38.60M
▲2.53M▲7.02%
3 Months ChangeFree Cash Flow
-20.95M
▲10.30M▲32.96%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 8-K
ID: 0000950170-24-116698
2024-08-14
Form 10-Q
ID: 0000950170-24-097073
2024-08-14
Form 8-K
ID: 0000950170-24-097054
2024-06-12
Form 8-K
ID: 0000950170-24-072467
2024-06-10
Form 8-K
ID: 0001193125-24-157911
2024-05-14
Form 10-Q
ID: 0000950170-24-059099
2024-05-14
Form 8-K
ID: 0000950170-24-059093
2024-03-27
Form 8-K
ID: 0000950170-24-037176
2024-03-27
Form 8-K
ID: 0000950170-24-036822
2024-03-21
Form 8-K
ID: 0000950170-24-034427